# FDA Inspection 1003267 - OneBlood, Inc. - January 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/d899fee2-ee43-4bc4-ab07-ec4a3ebd1435
Source feed: FDA_Inspections

> FDA Inspection 1003267 for OneBlood, Inc. on January 18, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1003267
- Company Name: OneBlood, Inc.
- Inspection Date: 2017-01-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1168490 - 2022-04-26](https://www.keypedia.com/records/fda_inspections/oneblood-inc/3ae4ac50-4190-4db9-9fc2-781ace388a56)
- [FDA Inspection 1168490 - 2022-04-26](https://www.keypedia.com/records/fda_inspections/oneblood-inc/6884cf11-f71b-4145-8142-d7623203baef)
- [FDA Inspection 1078409 - 2019-01-29](https://www.keypedia.com/records/fda_inspections/oneblood-inc/b8194cff-b0bd-4576-95ca-78b5971a17ec)
- [FDA Inspection 917091 - 2015-03-09](https://www.keypedia.com/records/fda_inspections/oneblood-inc/aa4f05d1-8f5b-4ad1-aa92-2ecb37fe2ebd)
- [FDA Inspection 826673 - 2013-04-10](https://www.keypedia.com/records/fda_inspections/oneblood-inc/44447e89-b269-4eaf-b2e7-395d20649bff)

Company: https://www.keypedia.com/companies/oneblood-inc/381a293c-64ea-48d8-ac52-7d3f7f2aac1c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d